logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Synchroneuron, Inc.


USPTO Granted Patents = 15



Forward Citations = 370

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Barry S Fogel (15 out of 20 patents)

silverMedal William D Kerns (5 out of 5 patents)

bronzeMedal Kei-Lai Fong (5 out of 5 patents)

4.  San-Laung Chow (1 out of 7 patents)

5.  Edward Lin (1 out of 1 patent)

6.  David N Wong (1 out of 33 patents)

7.  Edward Lin (0 patent)

8.  David Wong (0 patent)


15 patents:

1. 10512621 - Methods of treating posttraumatic stress disorder with acamprosate salts (2019-12-24),
2. 10166207 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2019-01-01),
3. 9427420 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-30),
4. 9421179 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),
5. 9421178 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),
6. 7745493 - Methods of treating tardive dyskinesia and other movement disorders (2010-06-29),
7. 7498361 - Methods of treating tardive dyskinesia and other movement disorders (2009-03-03),
8. 6689816 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2004-02-10),
9. 6391922 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2002-05-21),
10. 6294583 - Methods of treating tardive dyskinesia and other movement disorders (2001-09-25),
11. 6159944 - Method for treating painful conditions of the anal region and (2000-12-12),
12. 6117877 - Method for treating painful conditions of the anal region and (2000-09-12),
13. 6057373 - Methods of treating tardive dyskinesia and other movement disorders (2000-05-02),
14. 5952389 - Methods of treating tardive dyskinesia and other movement disorders (1999-09-14),
15. 5866585 - Methods of treating tardive dyskinesia using NMDA receptor antagonists (1999-02-02),
Synchroneuron, Inc. is a leading biotechnology company dedicated to developing novel therapies for neurological disorders. Our focus is on leveraging a deep understanding of synaptic transmission to pioneer groundbreaking treatments that address the underlying causes of conditions such as epilepsy, Parkinson's disease, and neuropathic pain. Through innovative research and strategic partnerships, we are committed to improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

15 Patents

#145 in Cambridge, MA

#1,231 in Massachusetts

#20,443 in US

#38,743 in the World

...
Cambridge, MA, United States of America

Synchroneuron, Inc.

Forward Citations = 370

6 inventors:

goldMedal Barry S Fogel (15 out of 20 patents)

silverMedal William D Kerns (5 out of 5 patents)

bronzeMedal Kei-Lai Fong (5 out of 5 patents)

4.  San-Laung Chow (1 out of 7 patents)

5.  Edward Lin (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com
Loading…